NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
This article is dedicated to a monogenic polysystemic disease — mucoviscidosis; its course severity and prognosis are to a large extend determined by the degree of lung affection, infection and chronic inflammatory process development in the airways. The authors show the derangement of the quality o...
Saved in:
Main Authors: | V. V. Chernikov, S. A. Krasovskiy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2012-10-01
|
Series: | Педиатрическая фармакология |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/294 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Antibacterial Activities of Tobramycin Inhalation Solutions
by: V. V. Pisarev
Published: (2020-05-01) -
CLINICAL AND PARACLINICAL FEATURES OF MUCOVISCIDOSIS COURSE OF CHILDREN OF AN EARLY AGE IN THE KRASNODAR REGION
by: E. M. Shadrina, et al.
Published: (2017-07-01) -
PRIMARY HEMOSTATIC SYSTEM CONDITION IN MUCOVISCIDOSIS IN CHILDREN
by: O. B. Gordeeva, et al.
Published: (2014-01-01) -
THE REGISTER AS A MEANS OF IMPROVING THE QUALITY OF MUCOVISCIDOSIS PATIENTS’ TREATMENT
by: I. K. Asherova, et al.
Published: (2012-06-01) -
ROLE OF THE KNOWN MUCOLYTICS IN MUCOVISCIDOSIS THERAPY
by: O. I. Simonova, et al.
Published: (2014-11-01)